Thrombotic Thrombocytopenic Purpura in a Patient With Triple‐Negative Breast Cancer Treated With <scp>PD</scp> ‐ <scp>L1</scp> Inhibition and Taxane Chemotherapy
Jason Ke, Albert C. Chong, Robert Y. Hsu, Anastasia Martynova, Noah Wald‐Dickler, Anishka D'souza, Caroline Piatek, G. In
原始摘要（英文原文）· Original abstract
Thrombocytopenic purpura (TTP) is a hematologic emergency that may occur with PD-L1 immunotherapy. New or worsening anemia and thrombocytopenia in patients started on PD-L1 inhibitors should raise suspicion for TTP and prompt workup for thrombotic microangiopathy.
Thrombotic Thrombocytopenic Purpura in a Patient With Triple‐Negative Breast Cancer Treated With <scp>PD</scp> ‐ <scp>L1</scp> Inhibition and Taxane Chemotherapy — 科研速览 Science Skim